دانشگاه بوعلی سینا

  اخبار و اعلانات

 آمار

تعداد نشریات22
تعداد شماره‌ها506
تعداد مقالات5,321
تعداد مشاهده مقاله10,082,762
تعداد دریافت فایل اصل مقاله6,725,268
Eslahi, Abolfazl, Rezvan, Hossein. (1404). ABCB1 Promoter Methylation: A Potential Biomarker and Therapeutic Target in the Pathogenesis of Ulcerative Colitis. پژوهش های زبان شناسی تطبیقی, (), -. doi: 10.22084/avr.2025.31673.1022
Abolfazl Eslahi; Hossein Rezvan. "ABCB1 Promoter Methylation: A Potential Biomarker and Therapeutic Target in the Pathogenesis of Ulcerative Colitis". پژوهش های زبان شناسی تطبیقی, , , 1404, -. doi: 10.22084/avr.2025.31673.1022
Eslahi, Abolfazl, Rezvan, Hossein. (1404). 'ABCB1 Promoter Methylation: A Potential Biomarker and Therapeutic Target in the Pathogenesis of Ulcerative Colitis', پژوهش های زبان شناسی تطبیقی, (), pp. -. doi: 10.22084/avr.2025.31673.1022
Eslahi, Abolfazl, Rezvan, Hossein. ABCB1 Promoter Methylation: A Potential Biomarker and Therapeutic Target in the Pathogenesis of Ulcerative Colitis. پژوهش های زبان شناسی تطبیقی, 1404; (): -. doi: 10.22084/avr.2025.31673.1022

ABCB1 Promoter Methylation: A Potential Biomarker and Therapeutic Target in the Pathogenesis of Ulcerative Colitis

Avicenna Veterinary Research
مقالات آماده انتشار، پذیرفته شده، انتشار آنلاین از تاریخ 20 آبان 1404
نوع مقاله: Original Article
شناسه دیجیتال (DOI): 10.22084/avr.2025.31673.1022
نویسندگان
Abolfazl Eslahi* 1؛ Hossein Rezvan2
1Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamedan, Iran
2Department of Pathobiology, Faculty of Veterinary Medicine, Bu-Ali Sina University, Hamadan, Iran
چکیده
The aim of this systematic review was to synthesize the existing evidence on the role of ABCB1 promoter methylation in the pathogenesis of ulcerative colitis (UC) and to evaluate its potential as a biomarker and therapeutic target. A systematic search was conducted across PubMed/MEDLINE, Scopus, Embase, Web of Science, and the Cochrane Library for articles published up to March 2024. Original human, animal, and cellular studies examining the association between ABCB1 methylation and UC were selected based on predetermined criteria, and their quality was assessed using standard tools. A total of 38 studies met the inclusion criteria. The evidence consistently indicated that ABCB1 promoter methylation levels in the colonic tissue of UC patients were significantly higher than in healthy individuals. A significant inverse correlation between increased methylation levels and decreased expression of ABCB1 mRNA and P-glycoprotein was reported in most studies. Furthermore, ABCB1 hypermethylation was associated with increased disease severity, a higher risk of relapse, and a poorer response to standard treatments. Laboratory studies demonstrated that pharmacological interventions and natural compounds could reverse this epigenetic alteration. Therefore, it can be concluded that ABCB1 promoter hypermethylation is an important epigenetic event in UC pathogenesis, contributing to intestinal barrier dysfunction and inflammation by silencing a key protective gene. This marker has high potential for application in the diagnosis, prognosis, and personalized treatment of UC.
کلیدواژه‌ها
Ulcerative colitis؛ DNA methylation؛ ABCB1؛ P-glycoprotein؛ biomarker
آمار
تعداد مشاهده مقاله: 0


سامانه مدیریت نشریات علمی. طراحی و پیاده سازی از سیناوب